Separation of plasma from whole blood by use of the cobas plasma separation card: A compelling alternative to dried blood spots for quantification of HIV-1 Viral Load

Journal of Clinical Microbiology

Volumn 57, Issue 4, 2018, Pages

  Carmona, Sergio ^a,b   Seiverth, Britta ^c   Magubane, Dieketseng ^b   Hans, Lucia ^a,b   Hoppler, Matthias ^c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^c Roche Diagnostics International   (Switzerland)

Author keywords

Cobas; Dried blood spots; Filter paper cards; HIV; HIV patient monitoring; Plasma; Plasma separation card; Viral load

Indexed keywords

EDETIC ACID; VIRUS RNA;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BLOOD STORAGE; CAPILLARY BLOOD; CELL INTERACTION; CONTROLLED STUDY; DRIED BLOOD SPOT TESTING; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; PLASMA; PRICK TEST; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TEMPERATURE; VEIN PUNCTURE; VIRUS CLASSIFICATION; VIRUS LOAD; BLOOD; DEVICES; FILTRATION; ISOLATION AND PURIFICATION; PAPER; PROCEDURES; SPECIMEN HANDLING; VIROLOGY;

ADULT; BLOOD SPECIMEN COLLECTION; DRIED BLOOD SPOT TESTING; FILTRATION; HIV INFECTIONS; HIV-1; HUMANS; LIMIT OF DETECTION; PAPER; PLASMA; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TEMPERATURE; VIRAL LOAD;

EID: 85064117774     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01336-18     Document Type: Article

References (36)

1. Rutherford GW, Anglemyer A, Easterbrook PJ, Horvath T, Vitoria M, Penazzato M, Doherty MC. 2014. Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failure. AIDS 28:S161-S169. https://doi.org/10.1097/ QAD.0000000000000236.
2. WHO. 2017. What's new in treatment monitoring: viral load and CD4 testing? WHO, Geneva, Switzerland.
3. Barth RE, van der Loeff MF, Schuurman R, Hoepelman AI, Wensing AM. 2010. Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review. Lancet Infect Dis 10:155-166. https://doi.org/10.1016/S1473-3099(09)70328-7.
4. Phillips A, Shroufi A, Vojnov L, Cohn J, Roberts T, Ellman T, Bonner K, Rousseau C, Garnett G, Cambiano V, Nakagawa F, Ford D, Bansi-Matharu L, Miners A, Lundgren JD, Eaton JW, Parkes-Ratanshi R, Katz Z, Maman D, Ford N, Vitoria M, Doherty M, Dowdy D, Nichols B, Murtagh M, Wareham M, Palamountain KM, Chakanyuka Musanhu C, Stevens W, Katzenstein D, Ciaranello A, Barnabas R, Braithwaite RS, Bendavid E, Nathoo KJ, van de Vijver D, Wilson DP, Holmes C, Bershteyn A, Walker S, Raizes E, Jani I, Nelson LJ, Peeling R, Terris-Prestholt F, Murungu J, Mutasa-Apollo T, Hallett TB, Revill P. 2015. Sustainable HIV treatment in Africa through viral-load-informed differentiated care. Nature 528:S68-S76. https://doi .org/10.1038/nature16046.
5. Sigaloff KC, Hamers RL, Wallis CL, Kityo C, Siwale M, Ive P, Botes ME, Mandaliya K, Wellington M, Osibogun A, Stevens WS, van Vugt M, de Wit TF. 2011. Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa. J Acquir Immune Defic Syndr 58:23-31. https://doi.org/10 .1097/QAI.0b013e318227fc34.
6. Rawizza HE, Chaplin B, Meloni ST, Eisen G, Rao T, Sankale JL, Dieng-Sarr A, Agbaji O, Onwujekwe DI, Gashau W, Nkado R, Ekong E, Okonkwo P, Murphy RL, Kanki PJ, APIN PEPFAR Team. 2011. Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings. Clin Infect Dis 53:1283-1290. https://doi.org/10.1093/cid/cir729.
7. van Oosterhout JJ, Brown L, Weigel R, Kumwenda JJ, Mzinganjira D, Saukila N, Mhango B, Hartung T, Phiri S, Hosseinipour MC. 2009. Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria. Trop Med Int Health 14: 856-861. https://doi.org/10.1111/j.1365-3156.2009.02309.x.
8. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2014. 90-90-90: an ambitious treatment target to help end the AIDS epidemic. UNAIDS/ JC2684. UNAIDS, Geneva, Switzerland.
9. Carmona S, Peter T, Berrie L. 2017. HIV viral load scale-up: multiple interventions to meet the HIV treatment cascade. Curr Opin HIV AIDS 12:157-164. https://doi.org/10.1097/COH.0000000000000352.
10. Parker SP, Cubitt WD. 1999. The use of the dried blood spot sample in epidemiological studies. J Clin Pathol 52:633-639. https://doi.org/10 .1136/jcp.52.9.633.
11. McAllister G, Shepherd S, Templeton K, Aitken C, Gunson R. 2015. Long term stability of HBsAg, anti-HBc and anti-HCV in dried blood spot samples and eluates. J Clin Virol 71:10-17. https://doi.org/10.1016/j.jcv .2015.07.303.
12. Greenman J, Roberts T, Cohn J, Messac L. 2015. Dried blood spot in the genotyping, quantification and storage of HCV RNA: a systematic literature review. J Viral Hepat 22:353-361. https://doi.org/10.1111/ jvh.12345.
13. Singh D, Dhummakupt A, Siems L, Persaud D. 2017. Alternative sample types for HIV-1 antiretroviral drug resistance testing. J Infect Dis 216: S834-S837. https://doi.org/10.1093/infdis/jix386.
14. Waitt C, Diliiy Penchala S, Olagunju A, Amara A, Else L, Lamorde M, Khoo S. 2017. Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 1060:300-307. https://doi .org/10.1016/j.jchromb.2017.06.012.
15. Calcagno A, Motta I, Milia MG, Rostagno R, Simiele M, Libanore V, Fontana S, D'Avolio A, Ghisetti V, Di Perri G, Bonora S. 2015. Dried plasma/blood spots for monitoring antiretroviral treatment efficacy and pharmacokinetics: a cross-sectional study in rural Burundi. Br J Clin Pharmacol 79:801-808. https://doi.org/10.1111/bcp.12544.
16. van Loo IHM, Dukers-Muijrers N, Heuts R, van der Sande MAB, Hoebe C. 2017. Screening for HIV, hepatitis B and syphilis on dried blood spots: a promising method to better reach hidden high-risk populations with self-collected sampling. PLoS One 12:e0186722. https://doi.org/10.1371/ journal.pone.0186722.
17. Schlusser KE, Pilcher C, Kallas EG, Santos BR, Deeks SG, Facente S, Keating SM, Busch MP, Murphy G, Welte A, Quinn T, Eshleman SH, Laeyendecker O. 2017. Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma. PLoS One 12:e0172283. https://doi.org/10.1371/journal.pone.0172283.
18. Sinunu MA, Schouten EJ, Wadonda-Kabondo N, Kajawo E, Eliya M, Moyo K, Chimbwandira F, Strunin L, Kellerman SE. 2014. Evaluating the impact of prevention of mother-to-child transmission of HIV in Malawi through immunization clinic-based surveillance. PLoS One 9:e100741. https://doi .org/10.1371/journal.pone.0100741.
19. Rutstein SE, Hosseinipour MC, Kamwendo D, Soko A, Mkandawire M, Biddle AK, Miller WC, Weinberger M, Wheeler SB, Sarr A, Gupta S, Chimbwandira F, Mwenda R, Kamiza S, Hoffman I, Mataya R. 2015. Dried blood spots for viral load monitoring in Malawi: feasible and effective. PLoS One 10:e0124748. https://doi.org/10.1371/journal.pone.0124748.
20. Hannon WH, Therell BL, Jr. 2014. Overview of the history and applications of dried blood spot samples, p. 3-15. In Li W, Lee MS (ed), Dried blood spots: applications and techniques. Wiley, Hoboken, NJ.
21. Parr JB, Lodge EK, Holzmayer V, Pepin J, Frost EH, Fried MW, McGivern DR, Lemon SM, Keeler C, Emch M, Mwandagalirwa K, Tshefu A, Fwamba F, Muwonga J, Meshnikk SR, Cloherty G. 2017. An efficient, large-scale survey of hepatitis C viremia in the Democratic Republic of the Congo using dried blood spots. Clin Infect Dis 66:254-260. https://doi.org/10 .1093/cid/cix771.
22. Zida S, Tuaillon E, Barro M, Kwimatouo Lekpa Franchard A, Kagone T, Nacro B, Ouedraogo AS, Bollore K, Sanosyan A, Plantier JC, Meda N, Sangare L, Rouzioux C, Rouet F, Kania D. 2016. Estimation of HIV-1 DNA level interfering with reliability of HIV-1 RNA quantification performed on dried blood spots collected from successfully treated patients. J Clin Microbiol 54:1641-1643. https://doi.org/10.1128/JCM.03372-15.
23. Parkin NT. 2014. Measurement of HIV-1 viral load for drug resistance surveillance using dried blood spots: literature review and modeling of contribution of DNA and RNA. AIDS Rev 16:160-171.
24. Guichet E, Serrano L, Laurent C, Eymard-Duvernay S, Kuaban C, Vidal L, Delaporte E, Ngole EM, Ayouba A, Peeters M. 2018. Comparison of different nucleic acid preparation methods to improve specific HIV-1 RNA isolation for viral load testing on dried blood spots. J Virol Methods 251:75-79. https://doi.org/10.1016/j.jviromet.2017.10.014.
25. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Office of Device Evaluation. 2016. Applying human factors and usability engineering to medical devices. Guidance for industry and Food and Drug Administration staff. FDA-2011-D-0469. U.S. FDA, Silver Spring, MD.
26. International Organization for Standardization. 2015. Medical devices-part 1: application of usability engineering to medical devices. IEC 62366-1:2015. International Organization for Standardization, Geneva, Switzerland.
27. Smit PW, Sollis KA, Fiscus S, Ford N, Vitoria M, Essajee S, Barnett D, Cheng B, Crowe SM, Denny T, Landay A, Stevens W, Habiyambere V, Perriens JH, Peeling RW. 2014. Systematic review of the use of dried blood spots for monitoring HIV viral load and for early infant diagnosis. PLoS One 9:e86461. https://doi.org/10.1371/journal.pone.0086461.
28. Schmitz ME, Agolory S, Junghae M, Broyles LN, Kimeu M, Ombayo J, Umuro M, Mukui I, Alwenya K, Baraza M, Ndiege K, Mwalili S, Rivadeneira E, Ng'ang'a L, Yang C, Zeh C. 2017. Field evaluation of dried blood spots for HIV-1 viral load monitoring in adults and children receiving antiretroviral treatment in Kenya: implications for scale-up in resource-limited settings. J Acquir Immune Defic Syndr 74:399-406. https://doi.org/10 .1097/QAI.0000000000001275.
29. Chang J, de Sousa A, Sabatier J, Assane M, Zhang G, Bila D, Vaz P, Alfredo C, Cossa L, Bhatt N, Koumans EH, Yang C, Rivadeneira E, Jani I, Houston JC. 2017. Performance characteristics of finger-stick dried blood spots (DBS) on the determination of human immunodeficiency virus (HIV) treatment failure in a pediatric population in Mozambique. PLoS One 12:e0181054. https://doi.org/10.1371/journal.pone.0181054.
30. Sawadogo S, Shiningavamwe A, Chang J, Maher AD, Zhang G, Yang C, Gaeb E, Kaura H, Ellenberger D, Lowrance DW. 2014. Limited utility of dried-blood-and plasma spot-based screening for antiretroviral treatment failure with Cobas Ampliprep/TaqMan HIV-1 version 2.0. J Clin Microbiol 52:3878-3883. https://doi.org/10.1128/JCM.02063-14.
31. Wu X, Crask M, Ramirez H, Landas T, Do TD, Honisch C, Will S, Baum PD. 2015. A simple method to elute cell-free HIV from dried blood spots improves their usefulness for monitoring therapy. J Clin Virol 65:38-40. https://doi.org/10.1016/j.jcv.2015.01.022.
32. Makadzange AT, Boyd FK, Chimukangara B, Masimirembwa C, Katzenstein D, Ndhlovu CE. 2017. A simple phosphate-buffered-saline-based extraction method improves specificity of HIV viral load monitoring using dried blood spots. J Clin Microbiol 55:2172-2179. https://doi.org/ 10.1128/JCM.00176-17.
33. Monleau M, Aghokeng AF, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Toure-Kane C, Truong LXT, Chaix M-L, Delaporte E, Ayouba A, Peeters M, Tang Y-W. 2014. Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia. J Clin Microbiol 52:578-586. https://doi.org/10.1128/JCM.02860-13.
34. Monleau M, Butel C, Delaporte E, Boillot F, Peeters M. 2010. Effect of storage conditions of dried plasma and blood spots on HIV-1 RNA quantification and PCR amplification for drug resistance genotyping. J Antimicrob Chemother 65:1562-1566. https://doi.org/10.1093/jac/ dkq205.
35. Wu G, Zaman MH. 2012. Low-cost tools for diagnosing and monitoring HIV infection in low-resource settings. Bull World Health Organ 90: 914-920. https://doi.org/10.2471/BLT.12.102780.
36. Aitken SC, Wallis CL, Stevens W, de Wit TR, Schuurman R. 2015. Stability of HIV-1 nucleic acids in dried blood spot samples for HIV-1 drug resistance genotyping. PLoS One 10:e0131541. https://doi.org/10.1371/ journal.pone.0131541.